stella
beta
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis — Stella
Recruiting
Back to Adult Patients With Moderately to Severely Active Ulcerative Colitis trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
The First Affiliated Hospital,Sun Yat-Sen University, Guangzhou, Guangdong
View full record on ClinicalTrials.gov